(2S)-2-[2-[3-[1-(1-acetylazetidin-3-yl)piperidin-4-yl]-1-propan-2-ylpyrazolo[4,3-b]pyridin-5-yl]-7-(4-chlorophenyl)-5-methyl-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid

C39H45ClN6O4S — CID 134464075

IUPAC(2S)-2-[2-[3-[1-(1-acetylazetidin-3-yl)piperidin-4-yl]-1-propan-2-ylpyrazolo[4,3-b]pyridin-5-yl]-7-(4-chlorophenyl)-5-methyl-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid
SMILESCC(=O)N1CC(N2CCC(c3nn(C(C)C)c4ccc(-c5nc6cc(C)c([C@H](OC(C)(C)C)C(=O)O)c(-c7ccc(Cl)cc7)c6s5)nc34)CC2)C1
InChIInChI=1S/C39H45ClN6O4S/c1-21(2)46-30-13-12-28(41-34(30)33(43-46)25-14-16-44(17-15-25)27-19-45(20-27)23(4)47)37-42-29-18-22(3)31(35(38(48)49)50-39(5,6)7)32(36(29)51-37)24-8-10-26(40)11-9-24/h8-13,18,21,25,27,35H,14-17,19-20H2,1-7H3,(H,48,49)/t35-/m0/s1
InChIKeyFDDWBOIIPDQUKR-DHUJRADRSA-N
MW729.35 g/mol
LogP8.27
Rot. Bonds8

About (2S)-2-[2-[3-[1-(1-acetylazetidin-3-yl)piperidin-4-yl]-1-propan-2-ylpyrazolo[4,3-b]pyridin-5-yl]-7-(4-chlorophenyl)-5-methyl-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid

(2S)-2-[2-[3-[1-(1-acetylazetidin-3-yl)piperidin-4-yl]-1-propan-2-ylpyrazolo[4,3-b]pyridin-5-yl]-7-(4-chlorophenyl)-5-methyl-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid (PubChem CID 134464075) has the molecular formula C39H45ClN6O4S and a molecular weight of 729.35 g/mol. Its IUPAC name is (2S)-2-[2-[3-[1-(1-acetylazetidin-3-yl)piperidin-4-yl]-1-propan-2-ylpyrazolo[4,3-b]pyridin-5-yl]-7-(4-chlorophenyl)-5-methyl-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid.

Molecular Properties

Compound Name(2S)-2-[2-[3-[1-(1-acetylazetidin-3-yl)piperidin-4-yl]-1-propan-2-ylpyrazolo[4,3-b]pyridin-5-yl]-7-(4-chlorophenyl)-5-methyl-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid
PubChem CID134464075
Molecular FormulaC39H45ClN6O4S
Molecular Weight729.35 g/mol
Exact Mass728.29
IUPAC Name(2S)-2-[2-[3-[1-(1-acetylazetidin-3-yl)piperidin-4-yl]-1-propan-2-ylpyrazolo[4,3-b]pyridin-5-yl]-7-(4-chlorophenyl)-5-methyl-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid
SMILESCC(=O)N1CC(N2CCC(c3nn(C(C)C)c4ccc(-c5nc6cc(C)c([C@H](OC(C)(C)C)C(=O)O)c(-c7ccc(Cl)cc7)c6s5)nc34)CC2)C1
InChIInChI=1S/C39H45ClN6O4S/c1-21(2)46-30-13-12-28(41-34(30)33(43-46)25-14-16-44(17-15-25)27-19-45(20-27)23(4)47)37-42-29-18-22(3)31(35(38(48)49)50-39(5,6)7)32(36(29)51-37)24-8-10-26(40)11-9-24/h8-13,18,21,25,27,35H,14-17,19-20H2,1-7H3,(H,48,49)/t35-/m0/s1
InChIKeyFDDWBOIIPDQUKR-DHUJRADRSA-N
XLogP8.27
TPSA113.68 Ų
H-Bond Donors1
H-Bond Acceptors9
Rotatable Bonds8
Heavy Atoms51
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500729.35
LogP ≤ 58.27
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 109

Analyze (2S)-2-[2-[3-[1-(1-acetylazetidin-3-yl)piperidin-4-yl]-1-propan-2-ylpyrazolo[4,3-b]pyridin-5-yl]-7-(4-chlorophenyl)-5-methyl-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-2-[2-[3-[1-(1-acetylazetidin-3-yl)piperidin-4-yl]-1-propan-2-ylpyrazolo[4,3-b]pyridin-5-yl]-7-(4-chlorophenyl)-5-methyl-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid?
The IUPAC name of (2S)-2-[2-[3-[1-(1-acetylazetidin-3-yl)piperidin-4-yl]-1-propan-2-ylpyrazolo[4,3-b]pyridin-5-yl]-7-(4-chlorophenyl)-5-methyl-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid (CID 134464075) is (2S)-2-[2-[3-[1-(1-acetylazetidin-3-yl)piperidin-4-yl]-1-propan-2-ylpyrazolo[4,3-b]pyridin-5-yl]-7-(4-chlorophenyl)-5-methyl-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid.
What is the SMILES notation for (2S)-2-[2-[3-[1-(1-acetylazetidin-3-yl)piperidin-4-yl]-1-propan-2-ylpyrazolo[4,3-b]pyridin-5-yl]-7-(4-chlorophenyl)-5-methyl-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid?
The canonical SMILES for (2S)-2-[2-[3-[1-(1-acetylazetidin-3-yl)piperidin-4-yl]-1-propan-2-ylpyrazolo[4,3-b]pyridin-5-yl]-7-(4-chlorophenyl)-5-methyl-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid is CC(=O)N1CC(N2CCC(c3nn(C(C)C)c4ccc(-c5nc6cc(C)c([C@H](OC(C)(C)C)C(=O)O)c(-c7ccc(Cl)cc7)c6s5)nc34)CC2)C1.
What is the InChIKey of (2S)-2-[2-[3-[1-(1-acetylazetidin-3-yl)piperidin-4-yl]-1-propan-2-ylpyrazolo[4,3-b]pyridin-5-yl]-7-(4-chlorophenyl)-5-methyl-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid?
The InChIKey is FDDWBOIIPDQUKR-DHUJRADRSA-N. The full InChI is InChI=1S/C39H45ClN6O4S/c1-21(2)46-30-13-12-28(41-34(30)33(43-46)25-14-16-44(17-15-25)27-19-45(20-27)23(4)47)37-42-29-18-22(3)31(35(38(48)49)50-39(5,6)7)32(36(29)51-37)24-8-10-26(40)11-9-24/h8-13,18,21,25,27,35H,14-17,19-20H2,1-7H3,(H,48,49)/t35-/m0/s1.
What are the key properties of (2S)-2-[2-[3-[1-(1-acetylazetidin-3-yl)piperidin-4-yl]-1-propan-2-ylpyrazolo[4,3-b]pyridin-5-yl]-7-(4-chlorophenyl)-5-methyl-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid?
(2S)-2-[2-[3-[1-(1-acetylazetidin-3-yl)piperidin-4-yl]-1-propan-2-ylpyrazolo[4,3-b]pyridin-5-yl]-7-(4-chlorophenyl)-5-methyl-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid has a molecular weight of 729.35 g/mol, XLogP of 8.27, 8 rotatable bonds, 1 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-2-[2-[3-[1-(1-acetylazetidin-3-yl)piperidin-4-yl]-1-propan-2-ylpyrazolo[4,3-b]pyridin-5-yl]-7-(4-chlorophenyl)-5-methyl-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid is sourced from PubChem (CID 134464075), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).